MATERNAL ANO PERINATAL OUTCOMES IN WOMEN WITH ANEMIA SICKLE CELL
Keywords:
anemia sickle cell, perinatal care, pregnancyAbstract
Objective
To evaluate the maternal-fetal complications presented by pregnant women with sick/e ce/1 disease, doing their pre-nata/ check-ups in the specialized pre-nata/ outpatients department of the Women's Health Center of the State University of Campinas, between January 2002 and July 2004.
Methods
The data were co//ected on a pre-codified form and analyzed using the Epi lnfo
6.0 program. Of the seven women with sick/e-ce/l anemia, six presented the homozygous form and one the double heterozygous form. Six of the women were negresses and one a ha/f-cast.
Results
The seven women showed changes in their clinica! evolution during pregnancy, but no maternal ar neonatal deaths occurred.
Conclusion
lt was concluded that maternal complications are more likely to occur in this popu/ation, but good prenatal care and contrai of the disease can improve the outcome.
Downloads
References
Brasil. Ministério da Saúde. Manual de doenças mais importantes por razões étnicas na população brasileira afro-descendente. Brasília: Ministério da Saúde; 2001.
Kikuchi BA. Anemia falciforme: manual para trabalhadores da saúde e educadores nas américas. 2.ed. Belo Horizonte: Health; 2003.
Zago MA. A anemia falciforme e doenças falciformes: manual de doenças mais importantes por razões étnicas, na população afro-descendentes. Brasília: Ministério da Saúde; 2001.
Paiva e Silva RB, Ramalho AS, Cassorla RMS. A anemia falciforme como problema de saúde pública no Brasil. Rev Saúde Pública. 1993; 27(1):54-8.
Rocha HHAG. Gravidez e anemia falciforme. ARS Cvrand. 2000; 33(5):31-3.
Gonçalvez MG, Ávila 1. Anemia falciforme e gravidez. Femina. 1985; 13(1):23-30.
Serjant GR. Sickle cell disease. 2nd ed. New York: Medical Publication; 1992.
Powards DR, Sandhu M, Niland-Weiss J, Johnson C, Bruce S, Manning PR. Pregnancy in sickle cell disease. Obst Gynecol. 1986; 67(2):217-28.
Pritchard JA, Scott DE, Whalley PH, Cunningham FG, Manson RA. The effects of maternal sickle cell hemoglobynopathies and cell trait on reproductive performance. Am J Obstet Gynecol. 1973; 117(5): 622-70.
Samuel F, etal. Pregnancy in sickle cell women: Review of 68 cases in Guadalupe. J Gynecol Biol Reprod. 2000; 29:86-93.
Koshy M, Burd L, Wallace D, Moawad A, Baron A. Prophylatic red cell transfusion in pregnant patients with sickle cell disease. N Eng J Med. 1988; 319(22): 1447-52.
Charache S, Scott J, Nubyl J, Bond D. Management of sickle cell disease in pregnancy patients. Obstet Gynecol. 1980; 55(4):407-10.
Milner PF, Jones BR, Dobler J. Outcome of pregnancy in sickle cell anemia and sickle cell hemoglobin C disease. Am J Obstet Gynecol. 1980; 138(3):239-45.
Koshi M. Sickle cell disease and pregnancy. Blood Rev. 1995; 9(3):157-64
Miller JM, Horger EO Ili, Key TC, Walker EM. Management of sickle hemopathies in pregnant patients. Am J Obstet Gynecol. 1981,141(30): 237-41.
Sun PM, Willburn W, Raynor D, Jamienson D. Sickle disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol. 2001; 184(6):1127-30.
Morrison JC, Blake PG, Reed C. Therapy for the pregnant patient with sickle hemoglobinopathies; a national focus. AM J Obst Gynecol. 1982; 144(3): 268-9.
Anderson M, Went LM, Maciver JE, Dixon HG. Sickle cell disease in pregnancy. Lancet. 1960; 3(2):516-21.
Silva HF. Anemia falciforme e gravidez: prognóstico materno-fetal [mestrado]. São Paulo: Faculdade de Medicina, Universidade de São Paulo; 1983.
Serjeant GR. A doença da célula falciforme. Anais Nestlé. 1999; 58:11-22.
